Expression of different HIV-1 phenotypic subpopulations through the natural history of the infection;Expresión de diferentes subpoblaciones fenotípicas del virus de la inmunodeficiencia humana tipo 1 a lo largo de la historia natural de la infección

Medicina Clinica

Volumn 110, Issue 12, 1998, Pages 441-445

  Pérez Álvarez, Lucía ^a   Verdejo, José ^b   González Lahoz, Juan ^b   Gurbindo, Dolores ^c   Hernández Sampelayo, Teresa ^c   Moreno, Elena ^a   Azañedo, Marta ^a   Contreras, Gerardo ^a   Medrano, Leandro ^a   Nájera, Rafael ^a,b  

^a U de Invest en Retrovirus   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE COURSE; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; PATHOGENICITY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PRESCHOOL CHILD; VIROLOGY; VIRUS REPLICATION;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INFANT; PHENOTYPE; VIRUS REPLICATION;

EID: 0032481709     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nájera R, Nájera I, De Andrés R, Medrano L, Pérez L, Contreras G. Epidemiología molecular del VIH. Pub of SEISIDA 1995; 6: 1-8.
2. Moutouh L, Corbeil J, Richman D. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996; 93: 6.106-6.111.
3. Nájera I. Variabilidad genética del VIH-1. En: Nájera R, González-Lahoz J, editores. Diagnóstico de laboratorio de la infección por VIH. Reuniones de Consenso sobre la infección por VIH. Madrid: SEISIDA, 1994; 16-22.
4. Perelson A, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1.582-1.586.
5. Fenyo EM, Fiore JM, Karlsson A, Albert J, Scarlatti G. Biological phenotypes of HIV-1 in pathogenesis and transmission. En: Giraldo G, Salvatore M, Chieco-Bianchi L, Beth-Giraldo E, editores. Advanced technologies in research, diagnosis and treatment of AIDS and in oncology. Antibiot Chemother Basel Karger 1994; 46: 18-24.
6. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 1-19.
7. Revised Clasification System for HIV infection in children less than 13 years of age. MMWR 1994; 43: 1-10.
8. Katzenstein TL, Pederson C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcomes. AIDS 1996; 10: 167-173.
9. Nielsen C, Pederson C, Lundgren JD, Gerstoft J. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993; 7: 1.035-1.040.
10. Soriano V, Heredia A, Bravo R, Gutiérrez M, González-Lahoz J. Progresión rápida a sida en un paciente infectado con una cepa del VIH-1 formadora de sincitios. Med Clin (Barc) 1995; 105: 99-100.
11. Roos MTL, Lange JMA, De Goede REY, Cotinho RA, Schellekens TA, Miedema F et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992; 165: 427-432.
12. Schuitemaker H, Koot M, Kootstra N, Dercksen MV, Goede REY, Steenwijk RP et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992; 66; 2: 1.354-1.360.
13. Koot M, Vos AHV, Keet RPM, Gode R, Dercksen M, Terpstra F et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992; 6: 49-54.
14. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994; 68; 7: 4.400-4.408.
15. Sanchez-Palomino, Rojas JM, Martinez MA, Fenyo MA, Nájera R, Domingo E et al. Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. J Virol 1993; 67: 2.938-2.943.
16. Sharer LR. Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992; 51: 3-11.
17. Wenig BM, Thompson LD, Frankel SS, Burke AP, Abbondazo SL, Sesterhenn I et al. Lymphoid changes of the nasopharingeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases. Am J Surg Pathol 1996; 20: 572-587.
18. Tersmette M, Schuitemaker H. Virulent HIV strains? AIDS 1993; 7: 1.123-1.125.
19. St Clair M. A novel phenotype identified in paediatric isolates. Xth International Conference on AIDS. Japón, 7-12 de agosto de 1994.